A Lazard review of activist campaigns for 2016 show that first-time insurgent campaigns represented about a quarter of all activism for the year – a record. Last month, startup fund Gilead Capital settled a brewing director-election proxy fight with Landauer to add one dissident director to the therapeutics and analytical services company’s board.